Sony and Cellares announced a joint development collaboration Sept. 12. The two companies say the partnership aims to integrate Sony’s cell-sorting and analytical technologies into the Cell Shuttle, ...
Technology Adoption Program (TAP) program success demonstrates the ability of Cellares’ IDMO Smart Factory to automate, lower costs and scale out manufacturing for Cabaletta Bio’s clinical-stage CAR T ...
Cellares, an Integrated Development and Manufacturing Organization (IDMO), concluded the Technology Adoption Program (TAP) on its automated cell therapy manufacturing Cell Shuttle™ for resecabtagene ...
Cellares to provide proof-of-concept manufacturing for a key BMS CAR-T cell therapy Cellares' proprietary Cell Shuttle is a cost-efficient, reliable, fully automated, and highly scalable manufacturing ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and commercial-scale cell therapy manufacturing, announced ...
Industry veteran brings two decades of platform commercialization experience in cell therapy, bioprocessing, and bioanalytics as Cellares prepares to support multiple clinical trials in 2026 ...
SOUTH SAN FRANCISCO, Calif. & MADISON, Wis.-- (BUSINESS WIRE)--Feb 18, 2026-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results